Entry Point Capital, LLC Humacyte, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 5,180 shares of HUMA stock, worth $29,215. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,180
Previous 32,128
83.88%
Holding current value
$29,215
Previous $99.9 Million
75.12%
% of portfolio
0.04%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
130Shares Held
30.8MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$40.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$26.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$16.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$10.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$9.02 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $581M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...